Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1992-03-13
1996-01-30
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
511 43, 511555, 511665, A61K 3166
Patent
active
054880424
ABSTRACT:
A method and pharmaceutical for protecting against genotoxic damage in irradiated cells. Reduction of mutations at the hypoxanthine-guanine phosphoribosyl transferase locus is accomplished by administering an effective dose of a compound having protected sulfhydryl groups which metabolize in vivo to produce both free sulfhydryl groups and disulfides.
REFERENCES:
patent: 3842824 (1975-07-01), Piper
patent: 5217964 (1993-06-01), Edwards
Smoluk, Cancer Research, 48 3641 (1985).
Livesy, Biochemical Pharmacology, 39 1807 (1990).
Sweeney, R. T., "A Survey of Compounds From the Antiradiation Drug Development Program of the U.S. Army Medical Research and Development Command," Walter Reed Army Institute of Research, Washington, D.C., Sep. 1979.
Corn, B. W., Liber, H. L. and Little, J. B., "Differential Effects of Radical Scavengers on X-Ray-Induced Mutation and Cytotoxicity in Human Cells," Radiation Research 109, 100-108 (1987).
Nygaard, O. F. and Simic, M. G., excerpt from Radioprotectors and Anticarcinogens, 73-85, (1983).
Grdina, D. J., Dale, P. and Weichselbaum, R., "Protection Against AZT-Induced Mutagenesis at the HGPRT Locus in Human Cell Line by WR-151326," submitted for publication in Jan. 1991 to The International Journal of Radiation Oncology, Biology, Physics; presented at the Seventh International Conference on Chemical Modifiers of Cancer Treatment, Clearwater, Florida, Feb. 2-5, 1991.
Milas, L., Hunter, N. and Stephens, L. C. and Peters, L. J., "Inhibition of Radiation Carcinogenesis in Mice by S-2(3-Aminopropylamino)-Methylphosphorothioic Acid," Cancer Research, vol. 44, 5567-5569, Dec. 1984.
Grdina, D. J., Carnes, B. A., Grahn, D. and Sigdestad, C. P. "Protection Against Radiation-Induced Late Effects S-2-(3-Aminopropylamino)-Ethylphosphorothioic Acid," submitted to Cancer Research for publication, Jan. 1991.
Brown, J. M., "Sensitizers and Protectors in Radiotherapy," Cancer, 2222-2228, May 1 Supplement, 1985.
Constine, L. S., Zagars, G., Rubin, P. and Kligerman, M., "Protection by WR-2721 of Human Bone Marrow Function Following Irradiation," Int. J. Radiation Oncology Biol. Phys., vol. 12, 1505-1508, (1986).
Mahoney, F., "Summary Statement," Radiation Study Section, Feb. 1986.
Grdina, D. J., Nagy, B., Hill, C. K. and Sigdestad, C. P., "Protection Against Radiation-Induced Mutagenesis in V79 Cells by 2-[(Aminoprophyl) amino] Ethanethiol Under Conditions of Acute Hypoxia," Radiation Research vol. 117, 251-258 (1989).
"Summary Statement," Radiation Study Section, Jan. 1989.
Maisin, J. R., Mattelin, G. and Lambiet-Collier, M., "Chemical Protection against the Long-Term Effects of a Single Whole-Body Exposure of Mice to Ionizing Radiation," Radiation Research 71, 119-131 (1977).
Kataoka, R., Basic, I., Perrin, J. and Grdina, D. J., "Anti-mutagenic effects of radioprotector WR-2721 against fission-spectrum-neutrons and Co-gamma rays in mice," submitted to Int. J. Radiation Oncology Biol. Phys. for publication in Mar. 1991.
Fry, R. J. M., "Radiation Carcinogenesis: Radioprotectors and Photosensitizers," Radioprotectors and Anticarcinogens, 417-436, (1983).
Held, K. D., "Models for Thiol Protection of DNA in Cells," Pharmac. Ther., vol. 39, 123-131, (1988).
Grdina, D. J. and Sigdestad, C. P., "Radiation Protectors: The Unexpected Benefits," Drug Metabolism Reviews, 20(1), 13-42, (1989).
"1990 AACR Abstract Form," Temporary Abst. No. 247, of the paper Antimutagenic and Anticarcinogenic Effects of Aminothiols: Applications to the Clinic and Workplace.
"Abstracts," 3rd International Conference on Anticarcinogenesis & Radiation Protection, Oct. 15-21, 1989.
"Abstracts," Twenty-Eighth Plenary Meeting of the Committee on Space Research, Jun. 25-Jul. 6, 1990.
Kataoka, Y., Basic, I., Perrin J. and Grdina, D. J., "Antimutagenic effects of radioprotector WR-2721 against fission-spectrum neutrons .sup.60 Co gamma-rays in mice,"Int. J. Radiat. Biol., (1992).
Zhang, X., Lai, P. and Taylor, Y., "Differential Radioprotection of Cultured Human Diploid Fibroblasts and Fibrosarcoma Cells by WR1065," International Journal of Radiation Oncology, Biology, Physics, vol. 21, Supp. 1, (1991).
Grdina, D. J., Kataoka, Y., Basic, I. and Perrin, J., "The radioprotector WR-2721 reduces neutron-induced mutations at the hypoxathine-guanine phosphoribosyl transferase locus in mouse splenocytes when administered prior to or following irradiation," submitted to Carcinogenesis for publication in 1991.
Grdina, D. J., Carnes, B. A., Grahn, D. and Sigdestad, C. P., "Protection against Late Effects of Radiation by S-2-(3-Aminopropylamino)-ethylphosphorothioic Acid," Cancer Research vol. 51, 4125-4130, Aug. 15, 1991.
Carnes, B. A. and Grdina, D. J., "In vivo protection by the aminothiol WR-2721 against neutron-induced carinogenesis," submitted to Int. J. Radiat. Biol. for publication in 1991.
Grdina, D. J., Wright, B. J. and Carnes, B. A., "Protection by WR-151327 against Late-Effect Damage from Fission-Spectrum Neutrons," Radiation Research 127, (1991).
Kataoka, Y., Perrin, J. and Grdina, D. J., "Protection by WR2721 Against Fission-Neutron-Induced Mutagenesis in Mice".
Kataoka, Y., Basic, I., Perrin, J. and Grdina, D. J., "Anti-mutagenic effects of radioprotector WR-2721 against fission-spectrum-neutrons and .sup.60 Co gamma-rays in mice," Int. J. Radiat. Biol., (1991).
Smoluik, G. D., Fahey, R. C., Calabro-Jones, P. M. Aguilera, J. A. and Ward, J. F., "Radioprotection of Cells in Culture by WR-2721 and Derivatives: Form of the Drug Responsible for Protection," Cancer Research vol. 48, 3641-3647, Jul. 1, 1988.
Holwitt, E. A., Koda, E. and Swenberg, C. E., "Enhancement of Topoisomerase I-Mediated Unwinding of Supercoiled DNA by the Radioprotector WR-33278," Radiation Research 124, 107-109, (1990).
Grdina and Sigdestad, "Exhibit 1," (FIG. 1-Radiation Inactivation of Mamalian Cells).
Benova, D., "Antimutagenic Properties of WR 2721 and of a Radioprotective Mixture, ATP-AET-Serotonin, With Regard to X-Ray Induced Reciprocal Translocations in Mouse Spermatogonia," Int. J. Radiation Oncology Biol. Phys., vol. 13, 117-119 (1987).
ARCH Development Corporation
Gerstl Robert
LandOfFree
Method for protection against genotoxic mutagenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for protection against genotoxic mutagenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for protection against genotoxic mutagenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-156655